Pericardiectomy after constrictive pericarditis associated with second dose of BNT162b2 vaccine: A case report

Huseyin Demirtas; Abdullah Ozer; Mehmet Burak Gulcan; Issa Shide; Hacı Delibas; Gürsel Levent Oktar

doi:10.5606/tgkdc.dergisi.2024.25357

Pericardiectomy after constrictive pericarditis associated with second dose of BNT162b2 vaccine: A case report

Turk Gogus Kalp Damar Cerrahisi Derg. 2024 Jan 29;32(1):97-100. doi: 10.5606/tgkdc.dergisi.2024.25357. eCollection 2024 Jan.

Authors

Huseyin Demirtas¹, Abdullah Ozer¹, Mehmet Burak Gulcan¹, Issa Shide¹, Hacı Delibas¹, Gürsel Levent Oktar¹

Affiliation

¹ Department of Cardiovascular Surgery, Gazi University Hospital, Ankara, Türkiye.

Abstract

Constrictive pericarditis is quite rare complication of messenger ribonucleic acid-based severe acute respiratory syndrome-Coronavirus 2 (SARS-CoV-2) vaccine. It is a severe clinical picture with clinical symptoms of right ventricular failure. Initial physical examination, laboratory work-up, and chest X-ray may yield non-specific findings. Echocardiography, computed tomography, and cardiac catheterization are other diagnostic tools. Surgery with pericardiectomy is the definitive treatment option. Herein, we report a case of pericardiectomy after constrictive pericarditis associated with the second dose of BNT162b2 vaccine.

Keywords: COVID-19 vaccines; Constrictive pericarditis; SARS-CoV-2.; mRNA vaccines; pericardiectomy.

Publication types

Case Reports